FDA Clears Catalyst OrthoScience Reverse Shoulder System

 Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system.

Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system.

Catalyst’s reverse shoulder system is a single-tray arthroplasty system that is made to combine beneficial and evidence-based attributes of reverse shoulder arthroplasty design. The system offers surgeon-targeted implant positioning, a streamlined and versatile system, and bone sparing implants.

With the addition of our reverse shoulder system, Catalyst is now addressing the two fastest-growing segments of the shoulder arthroplasty market – stemless anatomic and reverse TSA. This is beneficial for our distributors as well, who can now help surgeons more easily meet the needs of patients. – said Brian K. Hutchison, chairman, and CEO of Catalyst. 

Catalyst OrthoScience develops innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients. Catalyst was founded in 2014 by orthopedic surgeon Steven Goldberg, M.D., who saw the need to make shoulder replacement surgery less invasive and give patients a more natural-feeling shoulder after surgery.

Reversed Shoulder Implant Market Analysis and Forecast

Shoulder procedures accounted for nearly a quarter of total arthroscopic procedures performed in the U.S. In 2019 the reversed shoulder implant market was valued at over $656 million. It generated more than half of the total shoulder reconstruction market value in the U.S., being the second-fastest growing segment, with an annual growth rate of almost 8%.

Since the reversed shoulder implant device’s introduction in the United States in 2004, the market has grown rapidly. This market remains the largest segment in the U.S. shoulder reconstruction market. The device can be used in a variety of cases, from fractures to arthritis, and particularly in cases with massive rotator cuff tears. Despite marginal ASP decline across the market, reversed devices carry one of the highest prices, after those of the small revision shoulder implant market.

Register to receive a free US Small Bone and Joint Orthopedic Devices 2019 – 2025 synopsis

The reverse shoulder market’s growth is due to the increasing number of fractures that can be treated with this surgery (over plates and screws and nails, for instance). The indications for the reverse shoulder have also expanded, including both elderly and younger, more active patients with severe rotator cuff tears. More surgeons have become familiar with the reverse shoulder technique, and the popularity of the technique has grown, due to the number of successful outcomes.

Via: Orthospinenews

Leave a Reply